Is the US prepared to deal with another pandemic or widespread health crisis?

Short answer: The U.S. is more prepared than it was in 2020, but still not fully ready for a fast-moving, high-impact pandemic. Several core capabilities have improved, while persistent gaps and recent policy/funding volatility leave meaningful risk.

What’s stronger now

•Coordination and plans: A whole‑of‑government National Biodefense Strategy (updated October 2022) and a 2024 Global Health Security Strategy give clearer roles and goals; the White House Office of Pandemic Preparedness and Response Policy (OPPR) was created by Congress in December 2022 to drive policy coordination.[1]

•Data and forecasting: CDC’s Data Modernization Initiative launched the One CDC Data Platform (1CDP) and “Response Ready” capabilities, plus a Center for Forecasting and Outbreak Analytics that now supports real‑time modeling during outbreaks. These are tangible upgrades over the ad‑hoc systems of 2020.[2]

•Early warning: The National Wastewater Surveillance System (NWSS) has expanded to multiple pathogens (COVID‑19, flu, RSV, measles, and H5 avian influenza) and is being used operationally in responses, improving situational awareness.[3]

•Medical countermeasures: BARDA maintains a pre‑pandemic influenza vaccine stockpile (antigen, adjuvants, and seeds) and in 2024 expanded filled H5 doses with CSL Seqirus; FDA‑licensed H5 vaccines exist for stockpile use. HHS also released a 2025–2029 multiyear plan to strengthen the medical countermeasure pipeline and stockpile.[4]

•Health‑care and public‑health readiness funding: The CDC Public Health Emergency Preparedness (PHEP) program (FY 2026 request about $350M) and HHS’s Hospital Preparedness Program (HPP) (about $240M for Budget Period 3 beginning July 1, 2026) continue to underwrite planning, exercises, and surge readiness.[5]

•Cleaner indoor air: ASHRAE Standard 241 (2023) and updated EPA/CDC guidance give building owners actionable targets for ventilation/filtration to curb airborne transmission—tools many jurisdictions lacked pre‑COVID.[6]

Where the U.S. is still vulnerable

•Testing strategy and coordination: GAO found HHS still lacked a fully coordinated national diagnostic testing strategy; as of August 2026 HHS said a National Response Testing Framework was being finalized—years after COVID‑19 exposed this gap. GAO also reports many COVID‑era recommendations remain unimplemented (200 of 484 open as of March 31, 2025).[7]

•Workforce capacity: State and local health departments report persistent shortages and skills gaps (e.g., informatics), and pandemic‑era staffing gains were uneven and often temporary. This erodes readiness for prolonged responses.[8]

•Funding and authorities: The cornerstone Pandemic and All‑Hazards Preparedness Act (PAHPA) has been overdue for full reauthorization since 2023, creating uncertainty for key programs.[9]

•Surveillance stability: NWSS has proven value but has faced budget uncertainty, which threatens continuity of early‑warning capacity.[10]

•Countermeasure agility: Although the U.S. retains egg/cell/recombinant H5 vaccine options, cancellation of a large H5N1 mRNA contract in 2025 reduced diversification of platforms that could speed scale‑up if an H5 pandemic emerged.[11]

•Health‑care surge and integration: GAO says CDC’s PHEP and ASPR’s HPP need stronger, routine joint planning/exercises so public health and health‑care delivery don’t operate in silos during crises.[12]

Bottom line as of November 6, 2026: The U.S. has real advances in detection, data, coordination, and stockpiles compared with 2020. But unresolved testing governance, uneven workforce capacity, uncertain program authorities/funding, and incomplete health‑care/public‑health integration mean the nation is likely ready for moderate, regional events—but could still be stressed by a rapid, globally spreading respiratory pandemic.

If you have a specific scenario in mind (for example, pandemic influenza vs. a novel coronavirus, or a bioterror incident), I can give a more tailored readiness assessment and likely bottlenecks for that case.

1.[NATIONAL

BIODEFENSE
STRATEGY AND
IMPLEMENTATION](https://www.whitehouse.gov/wp-content/uploads/2022/10/National-Biodefense-Strategy-and-Implementation-Plan-Final.pdf?utm_source=openai)

Citations (12)

1whitehouse.govGovernment
NATIONAL BIODEFENSE STRATEGY AND IMPLEMENTATION
Backs: “A whole‑of‑government National Biodefense Strategy (updated October 2022) and a 2024 Global Health Security Strategy give clearer roles and goals; the White House Office of Pandemic Preparedness and Response Policy (OPPR) was created by Congress in December 2022 to drive policy coordination.”
2cdc.govGovernment
Data Modernization at CDC | Data Modernization | CDC
Backs: “These are tangible upgrades over the ad‑hoc systems of 2020.”
3cdc.govGovernment
About CDC's Wastewater Monitoring Program | Wastewater Monitoring | CDC
Backs: “The National Wastewater Surveillance System (NWSS) has expanded to multiple pathogens (COVID‑19, flu, RSV, measles, and H5 avian influenza) and is being used operationally in responses, improving situational awareness.”
4medicalcountermeasures.govGovernment
Medical Countermeasures | Influenza & Emerging Infectious Diseases (IED) Pandemic Vaccines & Adjuvants Program
Backs: “HHS also released a 2025–2029 multiyear plan to strengthen the medical countermeasure pipeline and stockpile.”
5cdc.govGovernment
FY 2026 CDC Congressional Justification
Backs: “The CDC Public Health Emergency Preparedness (PHEP) program (FY 2026 request about $350M) and HHS’s Hospital Preparedness Program (HPP) (about $240M for Budget Period 3 beginning July 1, 2026) continue to underwrite planning, exercises, and surge readiness.”
6ashrae.orgNonprofits and think tanks
ASHRAE Publishes Standard 241, Control of Infectious Aerosols | ashrae.org
Backs: “ASHRAE Standard 241 (2023) and updated EPA/CDC guidance give building owners actionable targets for ventilation/filtration to curb airborne transmission—tools many jurisdictions lacked pre‑COVID.”
7gao.govGovernment
Public Health Preparedness: HHS Needs a Coordinated National Approach for Diagnostic Testing for Pandemic Threats | U.S. GAO
Backs: “GAO also reports many COVID‑era recommendations remain unimplemented (200 of 484 open as of March 31, 2025).”
8gao.govGovernment
GAO-25-107002, PUBLIC HEALTH PREPAREDNESS: HHS and Jurisdictions Have Taken Some Steps to Address Challenging Workforce Gaps
Backs: “State and local health departments report persistent shortages and skills gaps (e.g., informatics), and pandemic‑era staffing gains were uneven and often temporary. This erodes readiness for prolonged responses.”
9everycrsreport.comEncyclopedias and referencequality 0.91
June 6, 2024
Backs: “The cornerstone Pandemic and All‑Hazards Preparedness Act (PAHPA) has been overdue for full reauthorization since 2023, creating uncertainty for key programs.”
10apnews.comNews and mediaquality 1.00
CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
Backs: “NWSS has proven value but has faced budget uncertainty, which threatens continuity of early‑warning capacity.”
11apnews.comNews and mediaquality 1.00
US cancels $766 million Moderna contract to fight pandemic flu | AP News
Backs: “Although the U.S. retains egg/cell/recombinant H5 vaccine options, cancellation of a large H5N1 mRNA contract in 2025 reduced diversification of platforms that could speed scale‑up if an H5 pandemic emerged.”
12gao.govGovernment
Public Health Preparedness: Improved Coordination Needed for HHS’s Emergency Preparedness Programs | U.S. GAO
Backs: “GAO says CDC’s PHEP and ASPR’s HPP need stronger, routine joint planning/exercises so public health and health‑care delivery don’t operate in silos during crises.”